Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool
Performance of a multi-cancer early detection test in the randomized controlled NHS-Galleri trial Nature
Study Unveils ‘Plug-and-Play’ CAR T Technology Designed to Adapt as Cancer Changes businesswire.com
Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study Nature
A Family with Deep CU Ties Supports a Home-Grown Study Seeking a Better Leukemia Treatment University of Colorado Anschutz
PATHFINDER 2 findings advance multi-cancer early detection blood testing OHSU News
Generic drug shows promise easing hot flashes from prostate cancer therapy foxcarolina.com
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according to a study published online Sept. 8 in ACR Open Rheumatology.
U.S. Cancer Mortality Declined 35% Since 1991, AACR Report Shows MedPage Today
Doctor Faced with Cancer Diagnosis Honored by San Diego Padres health.ucsd.edu
Local Treatment of the Primary Tumor in Metastatic Bladder Cancer After Exceptional Response - Ananya Choudhury & Alexandra Masson-Lecomte urotoday.com
Ovarian Cancer PFS Improves With Treatment Combo Physician's Weekly
Melanoma Research Alliance Pilot Award 2026–2027 Oncodaily
CMS said it is taking action to combat alleged fraud in the Affordable Care Act program. One expert told Healio the move could further strain the nation’s healthcare system. In a press conference Tuesday, Vice President JD Vance and CMS administrator Mehmet Oz, MD, announced CMS is canceling 315,000 “unauthorized…